Ascendis Pharma A/S - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Ascendis Pharma's 2020 Virtual Oncology R&D Day. (Operator Instruction].
I would now like to introduce your host for today's program, Scott Smith, Senior Vice President and Chief Financial Officer, at Ascendis Pharma. Please go ahead, Sir.
/- -
Thank you, operator, and thank you, everyone, for joining our first ever, and hopefully last virtual, Oncology R&D Day.
I'm Scott Smith, Chief Financial Officer of Ascendis. Joining me on today's call are Jan Mikkelsen, President and Chief Executive Officer; Kennett Sprogøe, Head of Innovation and Research; Dr. Juha Punnonen, Head of Oncology; Dr. Stina Singel, Head of Clinical Development Oncology; and Dr. Dana Pizzuti, Head of Development operations.
Turning to Slide 2. As you might have expected, we'll be making some forward-looking statements. Please refer to the Risk Factors section of our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
